BT Wealth Management LLC acquired a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,051 shares of the medical research company’s stock, valued at approximately $259,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Capital Financial Planning LLC bought a new stake in Thermo Fisher Scientific during the 4th quarter valued at about $27,000. Hanson McClain Inc. lifted its holdings in Thermo Fisher Scientific by 263.9% during the 4th quarter. Hanson McClain Inc. now owns 131 shares of the medical research company’s stock valued at $29,000 after buying an additional 95 shares in the last quarter. Capital Investment Advisory Services LLC bought a new stake in Thermo Fisher Scientific during the 4th quarter valued at about $35,000. Gradient Investments LLC raised its holdings in shares of Thermo Fisher Scientific by 1,887.5% in the 4th quarter. Gradient Investments LLC now owns 159 shares of the medical research company’s stock valued at $36,000 after purchasing an additional 151 shares in the last quarter. Finally, WESPAC Advisors SoCal LLC raised its holdings in shares of Thermo Fisher Scientific by 70.0% in the 4th quarter. WESPAC Advisors SoCal LLC now owns 170 shares of the medical research company’s stock valued at $38,000 after purchasing an additional 70 shares in the last quarter. Institutional investors own 88.66% of the company’s stock.
Several equities research analysts have recently commented on TMO shares. Bank of America restated a “buy” rating and issued a $300.00 price target (up previously from $285.00) on shares of Thermo Fisher Scientific in a report on Tuesday, April 16th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $310.00 price target for the company in a report on Tuesday, April 9th. BTIG Research boosted their price target on shares of Thermo Fisher Scientific to $310.00 and gave the company a “buy” rating in a report on Tuesday, March 26th. UBS Group boosted their price target on shares of Thermo Fisher Scientific to $305.00 and gave the company a “buy” rating in a report on Monday, March 25th. Finally, Deutsche Bank boosted their price target on shares of Thermo Fisher Scientific from $275.00 to $300.00 and gave the company a “buy” rating in a report on Friday, March 22nd. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $289.92.
Shares of Thermo Fisher Scientific stock traded up $2.27 on Friday, reaching $259.78. The stock had a trading volume of 2,960,104 shares, compared to its average volume of 1,554,358. The company has a quick ratio of 1.24, a current ratio of 1.73 and a debt-to-equity ratio of 0.64. Thermo Fisher Scientific Inc. has a 1 year low of $202.83 and a 1 year high of $282.98. The company has a market cap of $103.65 billion, a P/E ratio of 23.36, a PEG ratio of 1.71 and a beta of 1.13.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, January 30th. The medical research company reported $3.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.19 by $0.06. Thermo Fisher Scientific had a net margin of 12.06% and a return on equity of 16.86%. The firm had revenue of $6.51 billion for the quarter, compared to the consensus estimate of $6.26 billion. During the same quarter in the previous year, the firm earned $2.79 EPS. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, equities research analysts forecast that Thermo Fisher Scientific Inc. will post 12.16 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 16th. Stockholders of record on Friday, March 15th were given a $0.19 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.29%. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. Thermo Fisher Scientific’s payout ratio is presently 6.83%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Recommended Story: Buyback For Investors Defined
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.